866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Microbiome Therapeutics Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 125 Pages

In this report, the EMEA Microbiome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.



Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Microbiome Therapeutics for these regions, from 2012 to 2022 (forecast)

Europe: Germany, France, UK, Russia, Italy and Benelux;

Middle East: Saudi Arabia, Israel, UAE and Iran;

Africa: South Africa, Nigeria, Egypt and Algeria.



EMEA Microbiome Therapeutics market competition by top manufacturers/players, with Microbiome Therapeutics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

C3 Jian

Enterome Bioscience

Immuron

MicroBiome Therapeutics

OpenBiome

Osel

Ritter Pharmaceuticals

Second Genome

Seres Therapeutics

Synthetic Biologics

4D Pharma

AbbVie

ActoGeniX

Admera Health

Advanced Technology Ventures

Advancing Bio

AgBiome

AOBiome

APC Microbiome Institute

Assembly Biosciences

Avid Biotics

Azitra



On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

Probiotic Type

Fructo-Oligosaccharides

Galacto-Oligosaccharides

Inulin



On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Microbiome Therapeutics for each application, including

Antibiotic-Associated Diarrhoea (AAD)

Infectious Childhood Diarrhoea

Cholesterol

Inflammatory Bowel Disease (IBD)

Blood Pressure

Lactose Intolerance

Weight Loss

Vitamin Production

Bacterial Vaginosis (BV)

Others



If you have any special requirements, please let us know and we will offer you the report as you want.



Table of Contents

EMEA (Europe, Middle East and Africa) Microbiome Therapeutics Market Report 2017
1 Microbiome Therapeutics Overview
1.1 Product Overview and Scope of Microbiome Therapeutics
1.2 Classification of Microbiome Therapeutics
1.2.1 EMEA Microbiome Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Microbiome Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Probiotic Type
1.2.4 Fructo-Oligosaccharides
1.2.5 Galacto-Oligosaccharides
1.2.6 Inulin
1.3 EMEA Microbiome Therapeutics Market by Application/End Users
1.3.1 EMEA Microbiome Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Antibiotic-Associated Diarrhoea (AAD)
1.3.3 Infectious Childhood Diarrhoea
1.3.4 Cholesterol
1.3.5 Inflammatory Bowel Disease (IBD)
1.3.6 Blood Pressure
1.3.7 Lactose Intolerance
1.3.8 Weight Loss
1.3.9 Vitamin Production
1.3.10 Bacterial Vaginosis (BV)
1.3.11 Others
1.4 EMEA Microbiome Therapeutics Market by Region
1.4.1 EMEA Microbiome Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Microbiome Therapeutics (2012-2022)
1.5.1 EMEA Microbiome Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 EMEA Microbiome Therapeutics Revenue and Growth Rate (2012-2022)

2 EMEA Microbiome Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Microbiome Therapeutics Market Competition by Players/Manufacturers
2.1.1 EMEA Microbiome Therapeutics Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Microbiome Therapeutics Revenue and Share by Players (2012-2017)
2.1.3 EMEA Microbiome Therapeutics Sale Price by Players (2012-2017)
2.2 EMEA Microbiome Therapeutics (Volume and Value) by Type/Product Category
2.2.1 EMEA Microbiome Therapeutics Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Microbiome Therapeutics Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Microbiome Therapeutics Sale Price by Type (2012-2017)
2.3 EMEA Microbiome Therapeutics (Volume) by Application
2.4 EMEA Microbiome Therapeutics (Volume and Value) by Region
2.4.1 EMEA Microbiome Therapeutics Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Microbiome Therapeutics Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Microbiome Therapeutics Sales Price by Region (2012-2017)

3 Europe Microbiome Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Microbiome Therapeutics Sales and Value (2012-2017)
3.1.1 Europe Microbiome Therapeutics Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Microbiome Therapeutics Revenue and Growth Rate (2012-2017)
3.2 Europe Microbiome Therapeutics Sales and Market Share by Type
3.3 Europe Microbiome Therapeutics Sales and Market Share by Application
3.4 Europe Microbiome Therapeutics Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Microbiome Therapeutics Sales Volume by Countries (2012-2017)
3.4.2 Europe Microbiome Therapeutics Revenue by Countries (2012-2017)
3.4.3 Germany Microbiome Therapeutics Sales and Growth Rate (2012-2017)
3.4.4 France Microbiome Therapeutics Sales and Growth Rate (2012-2017)
3.4.5 UK Microbiome Therapeutics Sales and Growth Rate (2012-2017)
3.4.6 Russia Microbiome Therapeutics Sales and Growth Rate (2012-2017)
3.4.7 Italy Microbiome Therapeutics Sales and Growth Rate (2012-2017)
3.4.8 Benelux Microbiome Therapeutics Sales and Growth Rate (2012-2017)

4 Middle East Microbiome Therapeutics (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Microbiome Therapeutics Sales and Value (2012-2017)
4.1.1 Middle East Microbiome Therapeutics Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Microbiome Therapeutics Revenue and Growth Rate (2012-2017)
4.2 Middle East Microbiome Therapeutics Sales and Market Share by Type
4.3 Middle East Microbiome Therapeutics Sales and Market Share by Application
4.4 Middle East Microbiome Therapeutics Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Microbiome Therapeutics Sales Volume by Countries (2012-2017)
4.4.2 Middle East Microbiome Therapeutics Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2012-2017)
4.4.4 Israel Microbiome Therapeutics Sales and Growth Rate (2012-2017)
4.4.5 UAE Microbiome Therapeutics Sales and Growth Rate (2012-2017)
4.4.6 Iran Microbiome Therapeutics Sales and Growth Rate (2012-2017)

5 Africa Microbiome Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Microbiome Therapeutics Sales and Value (2012-2017)
5.1.1 Africa Microbiome Therapeutics Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Microbiome Therapeutics Revenue and Growth Rate (2012-2017)
5.2 Africa Microbiome Therapeutics Sales and Market Share by Type
5.3 Africa Microbiome Therapeutics Sales and Market Share by Application
5.4 Africa Microbiome Therapeutics Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Microbiome Therapeutics Sales Volume by Countries (2012-2017)
5.4.2 Africa Microbiome Therapeutics Revenue by Countries (2012-2017)
5.4.3 South Africa Microbiome Therapeutics Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Microbiome Therapeutics Sales and Growth Rate (2012-2017)
5.4.5 Egypt Microbiome Therapeutics Sales and Growth Rate (2012-2017)
5.4.6 Algeria Microbiome Therapeutics Sales and Growth Rate (2012-2017)

6 EMEA Microbiome Therapeutics Manufacturers/Players Profiles and Sales Data
6.1 C3 Jian
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Microbiome Therapeutics Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 C3 Jian Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Enterome Bioscience
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Microbiome Therapeutics Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Enterome Bioscience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Immuron
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Microbiome Therapeutics Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Immuron Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 MicroBiome Therapeutics
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Microbiome Therapeutics Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 MicroBiome Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 OpenBiome
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Microbiome Therapeutics Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 OpenBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Osel
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Microbiome Therapeutics Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Osel Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Ritter Pharmaceuticals
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Microbiome Therapeutics Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Second Genome
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Microbiome Therapeutics Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Seres Therapeutics
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Microbiome Therapeutics Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Synthetic Biologics
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Microbiome Therapeutics Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 4D Pharma
6.12 AbbVie
6.13 ActoGeniX
6.14 Admera Health
6.15 Advanced Technology Ventures
6.16 Advancing Bio
6.17 AgBiome
6.18 AOBiome
6.19 APC Microbiome Institute
6.20 Assembly Biosciences
6.21 Avid Biotics
6.22 Azitra

7 Microbiome Therapeutics Manufacturing Cost Analysis
7.1 Microbiome Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Microbiome Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Microbiome Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Microbiome Therapeutics Market Forecast (2017-2022)
11.1 EMEA Microbiome Therapeutics Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Microbiome Therapeutics Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Microbiome Therapeutics Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Microbiome Therapeutics Price and Trend Forecast (2017-2022)
11.2 EMEA Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Microbiome Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Microbiome Therapeutics Sales Forecast by Type (2017-2022)
11.7 EMEA Microbiome Therapeutics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Microbiome Therapeutics
Figure EMEA Microbiome Therapeutics Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Microbiome Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Probiotic Type Product Picture
Figure Fructo-Oligosaccharides Product Picture
Figure Galacto-Oligosaccharides Product Picture
Figure Inulin Product Picture
Figure EMEA Microbiome Therapeutics Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Microbiome Therapeutics by Application in 2016
Figure Antibiotic-Associated Diarrhoea (AAD) Examples
Figure Infectious Childhood Diarrhoea Examples
Figure Cholesterol Examples
Figure Inflammatory Bowel Disease (IBD) Examples
Figure Blood Pressure Examples
Figure Lactose Intolerance Examples
Figure Weight Loss Examples
Figure Vitamin Production Examples
Figure Bacterial Vaginosis (BV) Examples
Figure Others Examples
Figure EMEA Microbiome Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure Europe Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Microbiome Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Microbiome Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Microbiome Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Microbiome Therapeutics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Microbiome Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Microbiome Therapeutics Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Microbiome Therapeutics Sales Share by Players (2012-2017)
Figure 2016 Microbiome Therapeutics Sales Share by Players
Figure 2017 Microbiome Therapeutics Sales Share by Players
Figure EMEA Microbiome Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Microbiome Therapeutics Revenue (Million USD) by Players (2012-2017)
Table EMEA Microbiome Therapeutics Revenue Share by Players (2012-2017)
Table 2016 EMEA Microbiome Therapeutics Revenue Share by Players
Table 2017 EMEA Microbiome Therapeutics Revenue Share by Players
Table EMEA Microbiome Therapeutics Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Microbiome Therapeutics Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Microbiome Therapeutics Sales Share by Type (2012-2017)
Figure Sales Market Share of Microbiome Therapeutics by Type (2012-2017)
Figure EMEA Microbiome Therapeutics Sales Market Share by Type (2012-2017)
Table EMEA Microbiome Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Microbiome Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Microbiome Therapeutics by Type in 2016
Table EMEA Microbiome Therapeutics Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Microbiome Therapeutics Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Microbiome Therapeutics Sales Share by Application (2012-2017)
Figure Sales Market Share of Microbiome Therapeutics by Application (2012-2017)
Figure EMEA Microbiome Therapeutics Sales Market Share by Application in 2016
Table EMEA Microbiome Therapeutics Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Microbiome Therapeutics Sales Share by Region (2012-2017)
Figure Sales Market Share of Microbiome Therapeutics by Region (2012-2017)
Figure EMEA Microbiome Therapeutics Sales Market Share in 2016
Table EMEA Microbiome Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Microbiome Therapeutics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Microbiome Therapeutics by Region (2012-2017)
Figure EMEA Microbiome Therapeutics Revenue Market Share Regions in 2016
Table EMEA Microbiome Therapeutics Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2012-2017)
Table Europe Microbiome Therapeutics Sales (K Units) by Type (2012-2017)
Table Europe Microbiome Therapeutics Market Share by Type (2012-2017)
Figure Europe Microbiome Therapeutics Market Share by Type in 2016
Table Europe Microbiome Therapeutics Sales (K Units) by Application (2012-2017)
Table Europe Microbiome Therapeutics Market Share by Application (2012-2017)
Figure Europe Microbiome Therapeutics Market Share by Application in 2016
Table Europe Microbiome Therapeutics Sales (K Units) by Countries (2012-2017)
Table Europe Microbiome Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe Microbiome Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe Microbiome Therapeutics Sales Market Share by Countries in 2016
Table Europe Microbiome Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Europe Microbiome Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2016
Figure Germany Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure France Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure UK Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Microbiome Therapeutics Sales (K Units) by Type (2012-2017)
Table Middle East Microbiome Therapeutics Market Share by Type (2012-2017)
Figure Middle East Microbiome Therapeutics Market Share by Type (2012-2017)
Table Middle East Microbiome Therapeutics Sales (K Units) by Applications (2012-2017)
Table Middle East Microbiome Therapeutics Market Share by Applications (2012-2017)
Figure Middle East Microbiome Therapeutics Sales Market Share by Application in 2016
Table Middle East Microbiome Therapeutics Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Microbiome Therapeutics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Microbiome Therapeutics Sales Volume Market Share by Countries in 2016
Table Middle East Microbiome Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Microbiome Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East Microbiome Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East Microbiome Therapeutics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Microbiome Therapeutics Sales (K Units) by Type (2012-2017)
Table Africa Microbiome Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa Microbiome Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa Microbiome Therapeutics Sales Market Share by Type in 2016
Table Africa Microbiome Therapeutics Sales (K Units) by Application (2012-2017)
Table Africa Microbiome Therapeutics Sales Market Share by Application (2012-2017)
Figure Africa Microbiome Therapeutics Sales Market Share by Application (2012-2017)
Table Africa Microbiome Therapeutics Sales Volume (K Units) by Countries (2012-2017)
Table Africa Microbiome Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa Microbiome Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa Microbiome Therapeutics Sales Market Share by Countries in 2016
Table Africa Microbiome Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Africa Microbiome Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa Microbiome Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa Microbiome Therapeutics Revenue Market Share by Countries in 2016
Figure South Africa Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Table C3 Jian Microbiome Therapeutics Basic Information List
Table C3 Jian Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure C3 Jian Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure C3 Jian Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure C3 Jian Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Enterome Bioscience Microbiome Therapeutics Basic Information List
Table Enterome Bioscience Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Enterome Bioscience Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Enterome Bioscience Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Enterome Bioscience Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Immuron Microbiome Therapeutics Basic Information List
Table Immuron Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immuron Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Immuron Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Immuron Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table MicroBiome Therapeutics Microbiome Therapeutics Basic Information List
Table MicroBiome Therapeutics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MicroBiome Therapeutics Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure MicroBiome Therapeutics Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure MicroBiome Therapeutics Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table OpenBiome Microbiome Therapeutics Basic Information List
Table OpenBiome Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OpenBiome Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure OpenBiome Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure OpenBiome Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Osel Microbiome Therapeutics Basic Information List
Table Osel Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Osel Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Osel Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Osel Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Ritter Pharmaceuticals Microbiome Therapeutics Basic Information List
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ritter Pharmaceuticals Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Ritter Pharmaceuticals Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Ritter Pharmaceuticals Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Second Genome Microbiome Therapeutics Basic Information List
Table Second Genome Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Second Genome Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Second Genome Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Second Genome Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Seres Therapeutics Microbiome Therapeutics Basic Information List
Table Seres Therapeutics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seres Therapeutics Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Seres Therapeutics Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Seres Therapeutics Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Synthetic Biologics Microbiome Therapeutics Basic Information List
Table Synthetic Biologics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synthetic Biologics Microbiome Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Synthetic Biologics Microbiome Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Synthetic Biologics Microbiome Therapeutics Revenue Market Share in EMEA (2012-2017)
Table 4D Pharma Microbiome Therapeutics Basic Information List
Table AbbVie Microbiome Therapeutics Basic Information List
Table ActoGeniX Microbiome Therapeutics Basic Information List
Table Admera Health Microbiome Therapeutics Basic Information List
Table Advanced Technology Ventures Microbiome Therapeutics Basic Information List
Table Advancing Bio Microbiome Therapeutics Basic Information List
Table AgBiome Microbiome Therapeutics Basic Information List
Table AOBiome Microbiome Therapeutics Basic Information List
Table APC Microbiome Institute Microbiome Therapeutics Basic Information List
Table Assembly Biosciences Microbiome Therapeutics Basic Information List
Table Avid Biotics Microbiome Therapeutics Basic Information List
Table Azitra Microbiome Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2016
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders List
Figure EMEA Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Microbiome Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Microbiome Therapeutics Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Microbiome Therapeutics Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Microbiome Therapeutics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Microbiome Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Microbiome Therapeutics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Microbiome Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Microbiome Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Microbiome Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Microbiome Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Microbiome Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Microbiome Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Microbiome Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Microbiome Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Microbiome Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Microbiome Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Microbiome Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Microbiome Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Microbiome Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Microbiome Therapeutics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Microbiome Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Microbiome Therapeutics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *